Clinical Implications and Risk Factors for Erectile Dysfunction in Kidney Transplant: A Single-Center Assessment

• Published in: Curēus (Palo Alto, CA) Vol. 15; no. 4; p. e38088
• Main Authors: Miron, Adelina, Nistor, Ionut, Morosanu, Corneliu, Siriteanu, Lucian, Covic, Adrian
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 24-04-2023; Cureus
• Subjects: Age; Beta blockers; Body mass index; Diabetes; Enzymes; Erectile dysfunction; Hemodialysis; Hospitals; Hypertension; Kidney diseases; Kidney transplants; Laboratories; Nephrology; Patients; Peritoneal dialysis; Quality of life; Questionnaires; Risk factors; Sexual disorders; Surgical outcomes; Transplantation; Urology; chronic kidney disease; kidney transplant recipients; sexual dysfunction; renal transplant; erectile dysfunction
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.38088

Erectile dysfunction (ED) affects the great majority of people undergoing dialysis and also the majority of patients undergoing kidney transplantation. In this study, we investigated the degree of erectile dysfunction (ED), as well as its prevalence, contributory variables, and overall impact after renal transplant.
Adult male kidney transplant patients were the subject of an observational, non-interventional study that was conducted at a single center. Age, time and type of dialysis before transplantation, comorbidities, factors associated with cardiovascular risk, data on sexual history, physical examination, and laboratory results were among the clinical data we examined. In addition to gathering clinical and demographic characteristics, the International Index of Erectile Function (IIEF) questionnaire was used to evaluate sexual function.
A total of 170 renal transplanted patients between 20 and 70 years old (mean age: 45.40±11.5) were included in this study. All of the patients had immunosuppressive treatment with a calcineurin inhibitor (cyclosporine or tacrolimus) and had a normal glomerular filtration rate (GFR). The prevalence of sexual dysfunction increased with age (42.6% of patients under 40, 47.4% of patients in the 40-60 age group, and 78.9% of patients over 60). Mild, moderate, and severe ED was noted in 33.5%, 20.6%, and 10.6% of cases, respectively, and 51 (30%) patients reported having a normal sexual function. While calcium channel blockers (122 cases) were the most commonly used antihypertensive medication and chronic glomerulosclerosis (55.3%) was the most common cause of chronic kidney disease (CKD) before transplantation, none of these variables appear to have affected the severity of erectile dysfunction. The only medications associated with sexual dysfunction were alpha-blockers and aspirin (75 mg) (p=0.026 and p=0.013, respectively).
Although kidney transplantation has positive impacts on the quality of life, erectile dysfunction is a frequent condition among patients with renal transplants, and it has an increased frequency with age. In our study, it has been observed that only a small percentage of the research group had a normal sexual function, although most of the patients were young, and that alpha-blockers and aspirin (75 mg) are associated with erectile dysfunction.